Domov › Kolorektálny karcinóm › Washington
Klinické štúdie Kolorektálny karcinóm v štáte Washington
46 štúdií pre Kolorektálny karcinóm hľadá účastníkov v zariadeniach v štáte Washington.
Mestá v štáte Washington
- Seattle34 štúdií
- Tacoma9 štúdií
- Renton8 štúdií
- Spokane8 štúdií
- Kirkland7 štúdií
- Vancouver6 štúdií
- Everett5 štúdií
- Kennewick4 štúdií
- Walla Walla4 štúdií
- Spokane Valley4 štúdií
- Longview4 štúdií
- Bellingham4 štúdií
Oficiálny text štúdie (anglicky)
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Valley Medical Center, Renton
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05673148A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 281451, Seattle
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07525206The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1/2
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- a 19 ďalších
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069Family Communications After Genetic Testing
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- a 17 ďalších
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07143487Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06625775Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Fred Hutchinson Cancer Research Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06324357A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Virginia Mason Medical Center, Seattle
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07659795A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 271298, Seattle
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06820463Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Northwest Medical Specialties, PLLC, Bonney Lake
- Swedish Cancer Institute - Edmonds Campus, Edmonds
- Swedish Medical Center - Edmonds, Edmonds
- a 9 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Fred Hutchinson Cancer Center, Seattle
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT04981119A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- Swedish Cancer Institute, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06663319A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Providence Regional Cancer System, Lacey
- Fred Hutchinson Cancer Research Center, Seattle
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06750094A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Swedish Cancer Institute Edmonds, Edmonds
- Swedish Cancer Institute Issaquah, Issaquah
- Swedish Cancer Institute, Seattle
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06662786Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Northwest Medical Specialties, Tacoma
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06047379A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Local Institution - 0491, Edmonds
- Local Institution - 0253, Seattle
- Local Institution - 0629, Spokane
- a 1 ďalších
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07221357Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06445062Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Fred Hutchinson Cancer Research Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT05786924A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Vista Oncology Inc Ps, Olympia
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07284849Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Spokane
- Clinical Study Site, Tacoma
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT07228832The Vanguard Study: Testing a New Way to Screen for Cancer
- Madigan Army Medical Center, Tacoma
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 45 až 75 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06995898Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
- Benaroya Research Institute at Virginia Mason, Seattle
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06995924A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
- Swedish Cancer Institute, Seattle
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06992258MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT06586515Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
- University of Washington, Seattle
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT05410977A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 8. 2026 · NCT07066657A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Wenatchee Valley Hospital and Clinics, Wenatchee
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT06330064A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- GSK Investigational Site, Wenatchee
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06885034Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- University Of Washington, Seattle
Prebieha náborFáza 1
Vek 18 až 100 · Všetky pohlavia · Aktualizované 29. 7. 2026 · NCT06562192A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Georgetown University Medical Center, Georgetown
- Cancer Care Northwest, Spokane
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 7. 2026 · NCT03526835A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Providence Regional Cancer Partnership, Everett
- Providence Regional Medical Center Everett, Everett
- Northwest Cancer Specialists, P.C., Vancouver
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT05253651A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
- Medstar Speciality Hospital, Northwest
Prebieha náborFáza 4
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT06562543A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 45 až 75 · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT06822530A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Medical Oncology Associates, Spokane
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 6. 2026 · NCT07503808A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT06051695BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 6. 2026 · NCT06917079Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Virginia Mason Medical Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 5. 2026 · NCT05379985A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Virginia Mason Medical Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 4. 2026 · NCT07020221Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- a 17 ďalších
Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 3. 2026 · NCT07018869A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Fred Hutchinson Cancer Center, Seattle
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 3. 2026 · NCT06395519Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.